Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure Francisco J. Blanco, Esteban Rubio-Romero, Raimon Sanmartí, César Díaz-Torné, Pablo Talavera, Jochen Dunkel, Esperanza Naredo

Differences in the management of early and established rheumatoid arthritis Santos Castañeda, Federico Navarro, Cristina Fernández-Carballido, Carmelo Tornero, Elena Marced, Montserrat Corteguera

Predictors of response to biologic therapies in rheumatoid arthritis Lara M. Chaves Chaparro, Juan Salvatierra Ossorio, Enrique Raya Álvarez